Modification of Alternative Reward Cue Reactivity and Cognitive Control Through Physical Activity in Human Tobacco Use Disorder

January 10, 2024 updated by: Prof. Dr. Andreas Ströhle, Charite University, Berlin, Germany
This study investigates the mechanisms, through which physical exercise impacts positively on abstinence in tobacco use disorder, with fMRI and behavioral tests.

Study Overview

Detailed Description

This study will test the hypothesis that physical exercise training modifies alternative reward cue reactivity and cognitive control in tobacco use disorder and that these modifications mediate the effect of exercise on abstinence. Continued physical exercise training was shown to reduce tobacco consumption and prevent relapse in tobacco use disorder (TUD). However, the psychological and neural mechanisms through which exercise training exerts its effects on tobacco consumption are not clear. The aim of this project is to identify the effects of a 12-week aerobic exercise training in TUD and to test how these exercise-related changes may mediate the effect of exercise training on abstinence. Investigations will focus on two potential mechanisms of regaining control: (1) modifications of tobacco and alternative reward cue reactivity and (2) improvement of cognitive control. Two aspects of cognitive control will be addressed: inhibitory control and cognitive down-regulation of craving. It is expected, first, that exercise training (compared to standard treatment) leads to desensitization towards tobacco cues and sensitization towards alternative reward cues, reflected in altered craving and neural (fMRI) cue reactivity. Second, it is expected that exercise training will lead to increased cognitive control (i.e., inhibitory control and cognitive down-regulation of craving), reflected in increased activation of prefrontal control regions (fMRI). Third, it is expected that effects of exercise on abstinence will be mediated by sensitization towards alternative reward cues and enhanced cognitive control. In an exploratory manner, gender differences in the effects of exercise training will be studied. Understanding the psychological and neural underpinnings will help to optimize and individualize exercise trainings in TUD.

Study Type

Interventional

Enrollment (Actual)

82

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, 10117
        • Charité Universitätsmedizin Berlin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Tobacco use disorder according to DSM-5
  • right-handedness
  • sufficient ability to communicate with investigators
  • ability to provide informed consent and to use self-rating scales
  • seeking treatment for TUD
  • no contra-indication for aerobic exercise

Exclusion Criteria:

  • severe internal or neurological comorbidities
  • axis I mental disorders other than TUD (except for mild depression, adjustment disorder and specific phobias) in the last 12 months according to DSM-5
  • history of brain injury
  • pregnancy
  • exclusion criteria for MRI
  • positive drug screening (opioids, benzodiazepines, cocaine, amphetamines)
  • psychotropic medication within the last 14 days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise training plus smoking cessation group program
The moderate-intense aerobic exercise training will involve supervised aerobicycle ergometer training for 30 min with 60-80% HRmax three times per week for 12 weeks.
Participants of both groups will receive a 6-week standard cognitive behavioral therapy-oriented smoking cessation group program (SCP, one 60 min session per week).
Active Comparator: Smoking cessation group program
Participants of both groups will receive a 6-week standard cognitive behavioral therapy-oriented smoking cessation group program (SCP, one 60 min session per week).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in nicotine consumption from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
self-report
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
Change in nicotine consumption from pre-intervention to follow-up
Time Frame: Pre-intervention and follow-up (12 weeks after intervention end)
self-report
Pre-intervention and follow-up (12 weeks after intervention end)
Change in BOLD during cue reactivity task (fMRI) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
Blood Oxygen Level Dependent especially within the ventral striatum, the ventral medial prefrontal cortex and the amygdala during a cue reactivity task with neutral, tobacco, alternative reward images and warning images depicting aversive consequences of smoking
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
Change in BOLD during down-regulation of craving task (fMRI) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
Blood Oxygen Level Dependent especially within the ventral striatum, the amygdala and the dorsolateral prefrontal cortex during a cognitive down-regulation of craving task with tobacco and alternative reward stimuli
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
Change in BOLD during stop-signal task (fMRI) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
Blood Oxygen Level Dependent especially within the dorsolateral prefrontal cortex during a stop signal task
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
Change in craving ratings (behavioral) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
The participants' answers to the question "how strong is your desire to consume the item shown" on a scale of 1 - 8 is averaged over a total of 144 pictures of nicotine and alternative reward stimuli. The change in average ratings between pre-intervention and post-intervention is computed.
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
Change in down-regulation of craving (behavioral) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
The down-regulation of craving task is carried out as described in Kober et al., 2010. As described there, the down-regulation of craving is calculated as the difference in craving ratings between the now and later condition (20 nicotine and alternative reward stimuli are shown in the now and later condition). The change in the down-regulation of craving between pre- and post-intervention is then calculated.
Pre-intervention and post-intervention (up to 2 weeks after intervention end)
Change in stop-signal reaction time (behavioral) from pre-intervention to post-intervention
Time Frame: Pre-intervention and post-intervention (up to 2 weeks after intervention end)
Stop-signal reaction time in the stop-signal task
Pre-intervention and post-intervention (up to 2 weeks after intervention end)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

January 16, 2020

First Submitted That Met QC Criteria

January 30, 2020

First Posted (Actual)

February 5, 2020

Study Record Updates

Last Update Posted (Actual)

January 12, 2024

Last Update Submitted That Met QC Criteria

January 10, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Exercise training

3
Subscribe